
Vince and Associates CEO Dr. Bradley Vince Shares Physician Perspective on Subject Recruitment at Early Drug Development Conferences in Philadelphia and Cambridge
OVERLAND PARK, Kan., Nov. 3, 2010 /PRNewswire/ -- Vince and Associates Clinical Research (VACR), a leading provider of Phase I-III clinical trial research, announced that Dr. Bradley Vince, Medical Director and President, recently shared his expertise at two drug development industry meetings focused on accelerating early clinical development studies.
Dr. Vince presented to pharmaceutical and biotechnology industry executives at the Healthcare Business Institute Proof of Concept conference on September 26, 2010 in Philadelphia, PA and again at the Exploratory Development World Congress on October 20, 2010 in Cambridge, Massachusetts. Both meetings focused on early development strategies addressing the current need to rapidly advance new chemical entities into later stage clinical development and ultimately Food & Drug Administration (FDA) approval for commercialization.
Dr. Vince related his physician perspective on the recruitment and medical management aspects of Proof of Concept (POC) studies where new drugs are administered for the first time to human subjects in order to demonstrate drug efficacy in the targeted therapeutic area.
"As a multi-specialty research unit, we utilize our patient experience to recruit and execute complex Proof of Concept studies, which can include both healthy normal subjects and intent-to-treat patient populations," said Dr. Vince. "We welcomed the opportunity to share our perspective, medical expertise and strength in early-stage drug development at these conferences."
As Medical Director of Vince and Associates Clinical Research, Dr. Vince provides overall management of Phase I-III clinical pharmacology services, including study design, feasibility, recruiting and monitoring of both healthy normal subjects and disease-state populations participating in clinical trials at three facilities in Overland Park, KS.
About Vince and Associates Clinical Research
Vince and Associates Clinical Research is a dedicated research facility that conducts Phase I-III clinical trials for the global pharmaceutical and biotech industry. Dr. Vince has assembled an experienced team that focuses on quality research data and exceptional customer service while maintaining the highest ethical and professional standards. It has become one of the premier U.S. clinical research sites by utilizing a Physician Research Model of operation where study teams are led by highly experienced Principal Investigators intricately involved in all aspects of the clinical trial process.
With over a decade of experience and over 300 clinical trials completed, Vince and Associates is well known and respected for its rapid study start-up and track record of recruiting both healthy normal volunteers and patient populations.
More Information
Additional information about Vince and Associates Clinical Research can be found at www.vinceandassociates.com.
SOURCE Vince and Associates Clinical Research
Share this article